Latest filing published 01 Jul 2024 for Accelerate Diagnostics, Inc.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Louise Francesconi files at Stryker Corp (22 filings) and at Accelerate Diagnostics, Inc (four), both on Nasdaq, under the title Director. In all, 26 filings were published from March 23, 2016 to July 1, 2024, at four to five a year between 2016 and 2020, then one in 2023 and three in 2024.
The record holds seven sales, all at Stryker Corp, for EUR 4,847,524 and a median of EUR 480,884. Two stand out, a few thousand euros apart: EUR 1,461,852 on January 31, 2019 and EUR 1,455,376 on January 31, 2020. The third, EUR 574,657, is dated February 1, 2018. One purchase also appears, at Accelerate Diagnostics, Inc, with no amount recorded. The rest is 13 option exercises and five share grants.
Filings appear a median of 4 days after the trade, and no filing falls in the last twelve months.
Francesconi has 5, 2 and 2 own market trades within 30 days of colleagues at Stryker Corp, in that order. In the same direction: 1, 2 and 2. The colleagues, in the same order: Roch Doliveux, Glenn S. Boehnlein and Timothy J. Scannell.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations